The Latest Breaking News from Moderna

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

Experts hope new vaccines will be ready by end of decade

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

Exclusive: Pharmaceutical firm says groundbreaking jabs could save millions of lives

Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.

It was based on 860,000 patients across the world. The post Being vaccinated halves risk of long COVID: study appeared first on Talker.

Tuberculosis surrendered the title of the world’s deadliest infectious disease after COVID-19 struck, but it reclaimed that terrible distinction last year. As with COVID, a new vaccine could go a long way to sharply curtailing the disease, which killed about 1.4 million people a year before the pandemic and increased…

Sen. Bernie Sanders, who rose to national prominence criticizing big business in general and the pharmaceutical industry in particular, claimed the spotlight Wednesday on what might at first seem a powerful new stage from which to advance his agenda: chairmanship of the Senate health committee.

You might get the impression from the Biden administration's insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.

Photos of the week: Congress returned to Washington for a shortened work week this week.

WASHINGTON — Moderna CEO Stéphane Bancel attempted on Wednesday to win over lawmakers irate about the company’s planned COVID-19 vaccine price increase, weathering a barrage of criticism from Democrats angry at the company’s profits from its groundbreaking mRNA vaccine.